US EditionPublished • loading... • Updated
Extended Interval Dosing…When will it happen?…Do a pregnancy study
Summary by Multiple Sclerosis Research Blog
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Extended Interval Dosing…When will it happen?…Do a pregnancy study
Tweet We have made a suggestion that cladribine, alemtuzumab and anti-CD20 depleters work in the same way and this would suggest that if you dose 3 times (i.e. a year) then you may be able to “watch and wait” just like you do with alemtuzumab and cladribine. This study asks what happens when you stop ocrelizumab. Before I read on, I would think that it is inconcievable that some people will not show disease activity. With alemtuzumab this approa…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
